-
Dr. Oi-Lin Ng: Heterogeneity of Liver Cancer and its Biological Markers
-
APPLE 2023 | Lenvatinib, PD-1 inhibitors combined with radiotherapy safe and effective in treating hepatocellular carcinoma with portal vein tumor thrombus
-
Dr. Linda Wong: Adjuvant Therapy Could Usher in a New Paradigm for Early-Stage Liver Cancer Treatment
-
APPLE2023 | Application of Arterial Therapy in Early Hepatocellular Carcinoma: Korean Experience
-
Dr. Zhiren Chen: 3-year follow-up data from the START-FIT trial, showing an ORR of 67% for local advanced liver cancer patients
-
How to choose the maintenance treatment plan after HSCT for R/R malignanthematological patients?
-
Dr. Xingyu Cao: Post-transplant maintenance therapy with Chidamide in T-ALL patients is expected to reduce relapse and improve survival
-
Dr. Hui Wang: Unlocking a New Approach to MRD Testing in Acute Myeloid Leukemia
-
Dr. Min Xiong: Incorporating Cytarabine in the Pre-treatment for Haploidentical Hematopoietic Stem Cell Transplantation for Acute Leukemia with Extramedullary Disease is Safe and Effective
Connecting Medical Expertise through Media